v3 Template
N

Nura Bio

Biotechnology/Healthcare ~150 employees
Founded
--
Employees (Est.)
~150
10 leaders known
Total Funding
$141.8M
Funding Rounds
2
Last Funding
2026-06-22

About Nura Bio

Nura Bio envisions a world where neurological disorders are met with hope for a cure. The company aims to halt neurological diseases by targeting fundamental pathways underlying axon degeneration and neuroimmune regulation to preserve neuronal integrity.

Products & Services

Neuroprotective Therapies:Therapies focused on altering the course of neurological diseases through targeting axon degeneration and neuroimmune regulation.

Specialties

Neurological Disease Treatment Axon Degeneration Research Neuroimmune Regulation Neuroprotective Therapies axon degeneration neuroimmune regulation neurological diseases

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Series B
T: -
FT: Series B 		A: 73800000
MR: -
FA: $73.8M
FAN: 73800000 		D: 2026-06-22
FD: 2026-06-22 		4 investors
2 RT: Series A
T: -
FT: Series A 		A: 68000000
MR: -
FA: $68 Million
FAN: 68000000 		D: 2024-09-17
FD: 2024-09-17 		4 investors
Series B Latest
2026-06-22
$73.8M
4 investors (Pro only)
Series A 2024-09-17
$68.0M

View 1 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

S

Shilpa Sambashivan

Chief Executive Officer

L

Lahar Mehta

Chief Medical Officer

S

Scott Greenberg

Chief Business Officer

T

Tim Kutzkey

Board of Directors

S

Sanjay Keswani

Board of Directors

M

Mark Goldsmith

Board of Directors

View 7 more team members with Pro

Unlock Full Team Directory

Recent News

Nura Bio Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Biotechnology/Healthcare
Company Size
~150 employees (est.)

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro